Prefer to read in print? Subscribe for free here
If you would like to feature in the next issue of Pf Magazine, contact us here
April’s articles online:
Latest articles
Janssen presents initial results for BCMA CAR-T therapy
Janssen presents initial results for BCMA CAR-T therapy JNJ-4528 showing early, deep and high responses in the treatment of relapsed or refractory multiple myeloma. The...
Servier and UCL collaborate on immune-inflammatory disease treatments
Accelerating the discovery of new treatments for immune-inflammatory disease, including lupus and systemic sclerosis, is the focus of a new strategic research collaboration between...
Forendo and Novartis partner on novel chronic liver disease treatments
Forendo and Novartis are to partner on novel chronic liver disease treatments. Forendo Pharma, a clinical stage drug development company focusing on novel treatments...
Popular articles
Is the NHS a commercially viable market for pharma?
Claudia Rubin, Director at Decideum, questions how long the NHS will be a commercially viable market for pharma as she looks to 2020. “If you...
Does great brand planning make the difference?
As the hot summer days begin to fade behind us, thoughts start to turn towards next year. Teams are ramping up their planning activities...
Janssen presents initial results for BCMA CAR-T therapy
Janssen presents initial results for BCMA CAR-T therapy JNJ-4528 showing early, deep and high responses in the treatment of relapsed or refractory multiple myeloma. The...
How has 2019 shaped community pharmacies?
Deborah Evans, Managing Director of Pharmacy Complete, reflects on how 2019 has shaped the face of community pharmacy. 2019 has been an eventful year for...
Servier and UCL collaborate on immune-inflammatory disease treatments
Accelerating the discovery of new treatments for immune-inflammatory disease, including lupus and systemic sclerosis, is the focus of a new strategic research collaboration between...